Evotec AG has entered into a multi-year integrated drug discovery alliance with Genentech to discover novel small molecule therapeutics. Evotec will apply its drug discovery platform together with its disease biology expertise against targets selected by Genentech. This will include assay development and high throughput screening, medicinal chemistry and structural biology. The collaboration aims to deliver high quality leads and development candidates to support Genentech’s research ef...